AtriCure, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: B. Kristine Johnson

AtriCure, Inc.’s own tally for this item (“Elect Director: B. Kristine Johnson”): 41,685,893 for, 426,149 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,440,982 for, 1 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Deborah H. Telman

AtriCure, Inc.’s own tally for this item (“Elect Director: Deborah H. Telman”): 40,917,973 for, 1,192,573 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,415,786 for, 25,197 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Karen N. Prange

AtriCure, Inc.’s own tally for this item (“Elect Director: Karen N. Prange”): 41,514,921 for, 590,763 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,436,939 for, 4,044 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Maggie Yuen

AtriCure, Inc.’s own tally for this item (“Elect Director: Maggie Yuen”): 41,447,687 for, 663,914 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,423,241 for, 17,742 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Michael H. Carrel

AtriCure, Inc.’s own tally for this item (“Elect Director: Michael H. Carrel”): 41,848,141 for, 264,297 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,440,982 for, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Regina E. Groves

AtriCure, Inc.’s own tally for this item (“Elect Director: Regina E. Groves”): 41,852,934 for, 258,662 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,440,983 for, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Robert S. White

AtriCure, Inc.’s own tally for this item (“Elect Director: Robert S. White”): 41,025,795 for, 1,086,032 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,420,207 for, 20,775 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Shlomo Nachman

AtriCure, Inc.’s own tally for this item (“Elect Director: Shlomo Nachman”): 41,846,048 for, 260,889 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,440,983 for, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Election of Directors: Sven A. Wehrwein

AtriCure, Inc.’s own tally for this item (“Elect Director: Sven A. Wehrwein”): 41,454,342 for, 653,542 against, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,427,666 for, 13,317 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Description as filed by funds: Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 88 managers: 20,428,649 for, 55,132 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 2 managers: 702,273 for.

Description as filed by funds: Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 88 managers: 20,417,086 for, 9,562 against, 57,132 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 2 managers: 702,273 for.

Description as filed by funds: Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.

AtriCure, Inc.’s own tally for this item (“5. The compensation of the Company's named executive officers as disclosed in the proxy statement”): 40,373,427 for, 1,745,379 against — passed, per its Form 8-K filed May 19, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 90 managers: 20,458,388 for, 88,131 against, 55,132 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 240 managers: 26,899,412 for, 1,202,491 against, 513 abstained, 1,220 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: PROPOSAL TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AtriCure, Inc.’s own tally for this item (“2. The proposal to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 43,617,566 for, 2,327,505 against — passed, per its Form 8-K filed May 19, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved the proposal to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 20,421,319 for, 19,663 against, 55,132 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.